Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Assets Average (2024 - 2025)

CG Oncology's Assets Average history spans 2 years, with the latest figure at $760.8 million for Q4 2025.

  • For Q4 2025, Assets Average rose 16.39% year-over-year to $760.8 million; the TTM value through Dec 2025 reached $760.8 million, up 16.39%, while the annual FY2025 figure was $773.2 million, 62.08% up from the prior year.
  • Assets Average reached $760.8 million in Q4 2025 per CGON's latest filing, up from $715.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $760.8 million in Q4 2025 to a low of $389.2 million in Q1 2024.